Bumetanide
- Level
- Commodity
- Parent
- 51191500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51191504This classification denotes a loop diuretic with the molecular formula C17H20N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Y2S3XUQ5H, chemically known as benzoic acid, 3-(butylamino)-4-phenoxy-5-sulfamoyl- but generally known as bumetanide, which bears US NIH Compound Identifier 2471. European Medicines Agency schedules Bumetanide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05971MIG. The term BUMETANIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules bumetanide in its Anatomical Therapeutic Chemical (ATC) Classification. BUMETANIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bumetanide under HS 29350090 and SITC 51580. As of Q4 2014, BUMETANIDE remains the US FDA Preferred Term for this commodity. Bumetanide bears US NLM identifiers UMLS ID C0701009 and NCI Concept Code C28875. SMILES: S(=O)(=O)(N)C1C(OC2CCCCC2)C(NCCCC)CC(C1)C(=O)O.
Same parent
Under 51191500 · 77Activities that produce or sell this
KBLI · 9Inherited from family 51190000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.